Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities.
Cardin, Sophie
Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities. [electronic resource] - Blood advances 11 2019 - 3307-3321 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2473-9537
10.1182/bloodadvances.2019030981 doi
Animals
Biomarkers
Biomarkers, Tumor--genetics
Computational Biology--methods
Disease Models, Animal
Disease Susceptibility
Gene Expression
Gene Expression Profiling
High-Throughput Nucleotide Sequencing
Humans
Immunophenotyping
Leukemia, Megakaryoblastic, Acute--etiology
Mice
Neoplastic Stem Cells--metabolism
Nuclear Pore Complex Proteins--genetics
Oncogene Proteins, Fusion--genetics
Retinoblastoma-Binding Protein 2--genetics
Xenograft Model Antitumor Assays
Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities. [electronic resource] - Blood advances 11 2019 - 3307-3321 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2473-9537
10.1182/bloodadvances.2019030981 doi
Animals
Biomarkers
Biomarkers, Tumor--genetics
Computational Biology--methods
Disease Models, Animal
Disease Susceptibility
Gene Expression
Gene Expression Profiling
High-Throughput Nucleotide Sequencing
Humans
Immunophenotyping
Leukemia, Megakaryoblastic, Acute--etiology
Mice
Neoplastic Stem Cells--metabolism
Nuclear Pore Complex Proteins--genetics
Oncogene Proteins, Fusion--genetics
Retinoblastoma-Binding Protein 2--genetics
Xenograft Model Antitumor Assays